Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.52 |
| ▸ | RAB9A | P51151 | 7/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384504 | 1.00 | NPC1 (0.52) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL29382372 | 0.90 | NPC1 (0.45) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL4444924 | 0.90 | NPC1 (0.45) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL28880295 | 0.88 | NPC1 (0.39) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL4453092 | 0.88 | ELANE (0.43) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL5178883 | 0.87 | NPC1 (0.39) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL29992530 | 0.87 | NPC1 (0.41) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL29315615 | 0.85 | NPC1 (0.46) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL4439833 | 0.85 | NPC1 (0.54) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL4185113 | 0.83 | NPC1 (0.46) | NPC1RAB9ALMNAALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 365 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4713721-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4713720-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| US-20250052927-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2025-02-13 | — | — | US | claimed |
| WO-2025032504-A2 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2025-02-13 | — | — | WO | claimed |
| US-20240392055-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-11-28 | — | — | US | claimed |
| WO-2024236526-A2 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC. (CH) | 2024-11-21 | — | — | WO | claimed |
| WO-2024236524-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2024-11-21 | — | — | WO | claimed |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | ALCON INC (CH) | 2024-11-21 | — | — | US | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-11634558-B2 | Optical resin material for chromatic aberration correction | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-04-25 | — | — | US | claimed |
| US-20200270421-A1 | OPTICAL RESIN MATERIAL FOR CHROMATIC ABERRATION CORRECTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-08-27 | — | — | US | claimed |
| US-20060234035-A1 | Protective cover sheet comprising a UV-absorbing layer for a polarizer plate and method of making the same | EASTMAN KODAK COMPANY | 2006-10-19 | — | — | US | claimed |
| JP-10168408-A | — | — | None | — | — | JP | disclosed |
| WO-2026099827-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | ALCON INC. (CH) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132236-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | ALCON INC (CH) | 2026-05-14 | — | — | US | disclosed |
| EP-1055669-A1 | BISBENZOTRIAZOLYLPHENOL COMPOUNDS, ULTRAVIOLET ABSORBER, ULTRAVIOLET-ABSORBING POLYMER, AND RESIN COMPOSITION AND COATING MATERIAL BOTH CONTAINING THESE | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2000-11-29 | — | — | EP | disclosed |
| EP-1030194-A1 | Material for a soft intraocular lens | Menicon Co., Ltd. (JP) | 2000-08-23 | — | — | EP | disclosed |
| EP-0899091-A2 | Transparent coated molded product and method for producing the same | Asahi Glass Company Ltd. (JP) | 1999-03-03 | — | — | EP | disclosed |
| JP-H10168408-A | SELF-ADHESIVE TAPE OR SHEET | OJI PAPER CO LTD | 1998-06-23 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132236-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | RAD51, ERCC1, LANCL2 | NPC1 3423/4885RAB9A 4861/4885LMNA 543/4885 |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | NPC1 3998/4885RAB9A 4835/4885LMNA 2948/4885 |
| US-20240383865-A1 | HIGH-ENERGY-VIOLET-ABSORBING VINYLIC MONOMERS | VCL, HBS1L, SAAL1 | NPC1 4212/4885RAB9A 4844/4885LMNA 2529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.